DK1024795T3 - Formuleringer med reguleret frigivelse - Google Patents

Formuleringer med reguleret frigivelse

Info

Publication number
DK1024795T3
DK1024795T3 DK98950189T DK98950189T DK1024795T3 DK 1024795 T3 DK1024795 T3 DK 1024795T3 DK 98950189 T DK98950189 T DK 98950189T DK 98950189 T DK98950189 T DK 98950189T DK 1024795 T3 DK1024795 T3 DK 1024795T3
Authority
DK
Denmark
Prior art keywords
film
composition
forming
controlled release
water
Prior art date
Application number
DK98950189T
Other languages
Danish (da)
English (en)
Inventor
John Michael Newton
Lee Fung Siew
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of DK1024795T3 publication Critical patent/DK1024795T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK98950189T 1997-10-23 1998-10-23 Formuleringer med reguleret frigivelse DK1024795T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722426.5A GB9722426D0 (en) 1997-10-23 1997-10-23 Controlled release formulations
PCT/GB1998/003178 WO1999021536A1 (en) 1997-10-23 1998-10-23 Controlled release formulations

Publications (1)

Publication Number Publication Date
DK1024795T3 true DK1024795T3 (da) 2002-12-02

Family

ID=10820995

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98950189T DK1024795T3 (da) 1997-10-23 1998-10-23 Formuleringer med reguleret frigivelse

Country Status (10)

Country Link
US (1) US6534549B1 (de)
EP (1) EP1024795B1 (de)
JP (2) JP2001520986A (de)
AT (1) ATE221773T1 (de)
CA (1) CA2302585C (de)
DE (1) DE69807104T2 (de)
DK (1) DK1024795T3 (de)
ES (1) ES2178268T3 (de)
GB (1) GB9722426D0 (de)
WO (1) WO1999021536A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6929884B2 (en) 2001-04-19 2005-08-16 Zinc Matrix Power, Inc. Method for manufacture of films containing insoluble solids embedded in cellulose-based films
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
FR2862654B1 (fr) 2003-11-20 2006-02-10 Roquette Freres Composition amylacee filmogene
EP1547601A1 (de) 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
US20050260275A1 (en) * 2004-04-01 2005-11-24 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
US8048919B2 (en) * 2004-06-28 2011-11-01 Archer Daniels Midland Company Use of ethyl lactate as an excipient for pharmaceutical compositions
US7384916B2 (en) * 2005-03-16 2008-06-10 Procyte Corporation Methods and compositions for preventing and treating aging or photodamaged skin
US20090017110A1 (en) * 2005-05-31 2009-01-15 Capricorn Pharma Inc. Modified release formulations of anti-irritability drugs
GB0607534D0 (en) 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
US20090285863A1 (en) * 2006-07-27 2009-11-19 Gisela Fridrun Podczeck Coating Composition Comprising Starch
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
AU2009229167B2 (en) 2008-03-27 2014-01-23 Zpower, Llc Electrode separator
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
FR2934467B1 (fr) * 2008-07-31 2014-08-22 Roquette Freres Forme solide pelliculee et procede de pelliculage a temperature ambiante.
ES2425762T3 (es) * 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US8470885B2 (en) 2009-01-12 2013-06-25 Biokier, Inc. Composition and method for treatment of diabetes
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
EP2480246A4 (de) 2009-09-23 2013-02-27 Biokier Inc Zusammensetzung und verfahren zur behandlung von diabetes
EP2482822B1 (de) 2009-10-01 2018-08-01 Adare Pharmaceuticals, Inc. Oral verabreichte corticosteroid-zusammensetzungen
ES3033485T3 (en) 2010-11-15 2025-08-04 Archer Daniels Midland Co Compositions for converting contaminants
ES2655622T3 (es) 2012-04-30 2018-02-20 Tillotts Pharma Ag Una formulación de fármaco de liberación retardada
US20140271931A1 (en) * 2013-03-12 2014-09-18 Perosphere Inc. Anti-Acne Topical Films
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
AU2013404367B2 (en) 2013-10-29 2020-02-27 Tillotts Pharma Ag A delayed release drug formulation
EP3662901B1 (de) 2018-12-07 2025-01-01 Tillotts Pharma AG Arzeimittelformulierumg mit verzögerter freisetzung mit einer aussenschicht enthaltend ein enzymatisch abbaubares polymer, ihre zusammensetzung und ihr herstellungsverfahren
EP3662902B1 (de) 2018-12-07 2024-07-31 Tillotts Pharma AG Formulierung mit freisetzung eines wirkstoffs im kolon
EP3662900A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Kolonwirkstoffverabreichungsformulierung
EP3662898A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Feste formulierung enthaltend mesalazin
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations

Also Published As

Publication number Publication date
JP2001520986A (ja) 2001-11-06
EP1024795B1 (de) 2002-08-07
CA2302585A1 (en) 1999-05-06
ES2178268T3 (es) 2002-12-16
DE69807104D1 (de) 2002-09-12
DE69807104T2 (de) 2002-12-05
JP2010270335A (ja) 2010-12-02
ATE221773T1 (de) 2002-08-15
CA2302585C (en) 2007-09-25
GB9722426D0 (en) 1997-12-24
US6534549B1 (en) 2003-03-18
WO1999021536A1 (en) 1999-05-06
EP1024795A1 (de) 2000-08-09

Similar Documents

Publication Publication Date Title
DE69807104D1 (de) Formulierungen mit gesteuerter freisetzung
FI962111A0 (fi) Mikrokapseloidut 3-piperidinyyli-substituoidut 1,2-bentsisoksatsolit ja 1,2-bentsisotiatsolit
DE69832621D1 (de) Pharmazeutische formulierungen mit kontrollierter freigabe von wirkstoffen
ATE161174T1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
ES2173096T3 (es) Composicion farmaceutica peletizada.
IS2354B (is) Lyfjasamsetning sem mögulegt er að hleypa
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
PT1017367E (pt) Metodos para fabricar preparacoes de libertacao controlada baseadas em polimeros
DK0531611T3 (da) Matrix med reguleret frigivelse til lægemidler
SE8603247D0 (sv) Farmaceutiskt granulat
UA35569C2 (uk) Композиція для пролонгованого і контрольованого вивільнення пептидної лікарської речовини і спосіб її одержання, спосіб приготування суспензії, що призначена для парентерального введення
ES2171471T3 (es) Sistema para la administracion oral de desferrioxamina.
NO964410D0 (no) Matriks-pelleter med langsom frigiving, samt fremstilling av disse
KR900002769A (ko) 장시간 작용하는 나트륨 디클로페낙의 제제
IE860306L (en) Drug delivery system
NO985094D0 (no) Polymerpulver som er redispergerbart i vandige l°sninger
AU3483497A (en) Solid solution of an antifungal agent with enhanced bioavailability
EP0297866A3 (de) Arzneimittel
MY133341A (en) Expandable vinyl chloride resin composition
JPS5312978A (en) Isolation of low-molecular weight polymers
JPS56142208A (en) Prolongable prostaglandin transvaginal agent and its preparation
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer
TH2453A (th) สูตรผสมยาฆ่าพยาธิชนิดที่ละลายน้ำได้น้อยและกรรมวิธีสำหรับการ?เตรียมสูตรผสมต่าง ๆ นี้